Investigators developed and validated new PSMA-PET-based nomograms for prognostication across prostate cancer stages to help ...
First-in-human assessment of actinium-225-prostate-specific membrane antigen (225Ac-PSMA)-Trillium (BAY 3563254) in mCRPC: Dose-escalation results of the phase 1 PAnTHa study. Visual PSMA-PET and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results